# Novo Nordisk Inc. – FDA Inspection, Apr 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/1d5c8257-f349-440a-9ebf-72db3b05a4f4
Source feed: FDA_Inspections

> FDA inspection 1013344 of Novo Nordisk Inc., April 13, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013344
- Company Name: Novo Nordisk Inc.
- Inspection Date: 2017-04-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1255957 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/b68c3a3c-5d39-4d5e-b050-802a21bd26f0)
- FDA Inspection 1194065 - 2022-12-21
- FDA Inspection 1018484 - 2017-06-08
- FDA Inspection 983531 - 2016-07-22
- FDA Inspection 968597 - 2016-04-12

## Related Officers

- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)
- [Issuing Officer](https://www.keypedia.com/people/shirley-s-wen/eafbc8e5-a0ac-443a-adaf-ced505f77842)

Company: https://www.keypedia.com/companies/novo-nordisk-inc/920bb4ea-9450-45a6-bcd7-9f85c2f2bbad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
